Can You Take Losartan and Hydrochlorothiazide Together?

Yes, losartan and hydrochlorothiazide are frequently prescribed together and are considered safe for most patients when monitored appropriately. In fact, the FDA has approved combination products containing both medications specifically for blood pressure management. However, taking these two drugs together does require careful monitoring for electrolyte imbalances and blood pressure drops that can occur when both medications work synergistically on your kidneys and blood vessels.

What the FDA Says

The FDA recognizes losartan and hydrochlorothiazide as complementary antihypertensive agents and has approved several fixed-dose combination products that contain both drugs. These include brand names like Hyzaar (losartan potassium and hydrochlorothiazide). The approval of combination formulations indicates that when dosed appropriately and monitored, the two drugs can be used together safely.

However, both the FDA-approved labeling for losartan and the labeling for hydrochlorothiazide contain important warnings about specific risks when these medications are combined:

• Hyperkalemia risk: Losartan can increase potassium levels, while hydrochlorothiazide typically lowers potassium. The FDA labeling notes that when using ARBs (angiotensin II receptor blockers like losartan) with other agents that affect potassium, careful monitoring is necessary.
• Hypotension risk: Both drugs lower blood pressure through different mechanisms. Combined use increases the risk of excessive blood pressure drops, particularly in patients with volume depletion or those taking other blood pressure medications.
• Renal function changes: FDA labeling warns that angiotensin II receptor antagonists can cause changes in renal function, especially when combined with other drugs affecting the kidney's blood supply.
• Hyponatremia: Thiazide diuretics like hydrochlorothiazide can cause low sodium levels; this risk may be compounded when combined with losartan.

How This Interaction Works

To understand whether losartan and hydrochlorothiazide are truly safe together for you, it helps to know exactly how each drug works and where their effects intersect.

Losartan's mechanism: Losartan is an angiotensin II receptor blocker (ARB). It works by blocking the angiotensin II receptor on blood vessel walls and in the adrenal glands. Angiotensin II is a hormone that normally causes blood vessels to constrict and signals the kidneys to retain sodium and water. When losartan blocks this hormone, blood vessels relax and the kidneys excrete more sodium and water, both of which lower blood pressure.

A key side effect of losartan is that it increases potassium retention. This occurs because angiotensin II normally suppresses aldosterone, a hormone that tells the kidneys to conserve potassium. When losartan blocks angiotensin II, aldosterone activity increases, causing the kidneys to conserve even more potassium. This is why hyperkalemia (high potassium) is a known risk with ARBs.

Hydrochlorothiazide's mechanism: Hydrochlorothiazide is a thiazide diuretic. It blocks sodium and chloride reabsorption in the early distal convoluted tubule of the kidney's nephron. This prevents water reabsorption, increases urine output, and lowers blood volume and blood pressure. However, by increasing urine volume, thiazides also increase the urinary excretion of potassium, magnesium, and sometimes sodium.

The interaction: When both drugs are combined, their potassium effects theoretically counterbalance each other—losartan pushes potassium up, while hydrochlorothiazide pushes it down. In theory, this could create a neutral effect. However, in clinical practice, the balance is unpredictable. Some patients end up with dangerously high potassium (hyperkalemia), others develop low potassium (hypokalemia), and still others maintain normal levels. The outcome depends on your baseline kidney function, diet, age, other medications, and individual variation in drug response.

Additionally, both drugs act on the kidney's blood supply and fluid balance. The combined effect is a more pronounced drop in blood pressure and blood flow to the kidneys than either drug alone would produce. This is actually why they are prescribed together—the combination is more effective at lowering blood pressure than monotherapy. But it also means a greater risk of symptomatic hypotension (dizziness, fainting, weakness) and acute kidney injury if blood pressure drops too far or if the patient becomes dehydrated.

Who Is Most at Risk

While losartan and hydrochlorothiazide can be safely combined in many patients, certain groups face higher risks and require closer monitoring:

• Patients with chronic kidney disease: If your glomerular filtration rate (GFR) is already reduced, both drugs can further impair kidney function. Losartan is generally kidney-protective in diabetic kidney disease, but the combination with a diuretic can cause acute kidney injury if blood pressure drops too much.
• Older adults (age 65+): Aging reduces kidney function and makes you more sensitive to blood pressure drops. Older adults are at higher risk for hyperkalemia and symptomatic hypotension when on this combination.
• Patients with diabetes: Both losartan and hydrochlorothiazide have complex effects in diabetic patients. Losartan is renoprotective, but hydrochlorothiazide can worsen glucose control and increase the risk of hyperkalemia in the context of reduced kidney function from diabetes.
• Patients with liver cirrhosis or ascites: These patients have abnormal fluid and electrolyte regulation and are at high risk for dangerous electrolyte imbalances and acute kidney injury.
• Patients taking other potassium-raising drugs: If you are also on an ACE inhibitor, a potassium-sparing diuretic, NSAIDs, or potassium supplements, the risk of hyperkalemia increases significantly.
• Patients on high-dose combinations: The risk scales with dose. Losartan 100 mg plus hydrochlorothiazide 25 mg carries higher risk than losartan 50 mg plus hydrochlorothiazide 12.5 mg.
• Dehydrated or volume-depleted patients: If you have been vomiting, have severe diarrhea, or are not drinking enough fluids, the combination can cause severe hypotension and kidney damage.

Clinical Scenario 1: A Patient with Hypertension and Early Kidney Disease

Maria is a 62-year-old woman with type 2 diabetes and hypertension. Her recent lab work shows a GFR of 52 mL/min/1.73m² (Stage 3a chronic kidney disease) and serum potassium of 4.8 mEq/L (normal range 3.5–5.0). Her blood pressure is 156/92 mmHg despite being on amlodipine 5 mg daily.

Her cardiologist prescribed losartan 50 mg daily and hydrochlorothiazide 12.5 mg daily to better control her blood pressure and reduce proteinuria (a sign of kidney damage). This is a reasonable choice: losartan has proven renal protection in diabetic patients, and the modest dose of hydrochlorothiazide adds blood pressure control without causing excessive potassium loss.

However, Maria needs specific monitoring: potassium and creatinine levels should be checked 1–2 weeks after starting the combination, then every 3–6 months. If her potassium rises above 5.5 mEq/L or her creatinine increases by more than 30% from baseline, the doses should be reduced or one drug reconsidered. Maria should also be counseled not to use potassium salt substitutes, to limit NSAIDs, and to maintain consistent hydration. She should report symptoms like dizziness, unusual fatigue, or irregular heartbeats immediately.

Clinical Scenario 2: An Older Adult on Multiple Medications

Robert is a 74-year-old man with hypertension, mild chronic kidney disease (GFR 58), and a history of gout. He was recently prescribed losartan 100 mg and hydrochlorothiazide 25 mg (a higher-dose combination product) to control his blood pressure after a stroke prevention initiative.

Two weeks later, Robert reports dizziness when standing up, and his wife notices he seems more confused than usual. Lab work reveals his sodium is 128 mEq/L (low; normal is 135–145), his potassium is 6.1 mEq/L (elevated), and his creatinine has risen from 1.2 to 1.6 mg/dL. These are signs of acute electrolyte imbalance and worsening kidney function from the combination therapy.

Robert's case illustrates the importance of dose titration in older adults. The higher-dose combination was too aggressive for his age and baseline kidney function. His doctor reduced both doses to losartan 50 mg and hydrochlorothiazide 12.5 mg, ensured he was well-hydrated, and repeated labs in 1 week. His sodium and potassium normalized, and his creatinine stabilized. This scenario is common and entirely preventable with appropriate initial dosing and early monitoring.

What to Do

If you are currently on both losartan and hydrochlorothiazide:

• Do not stop either medication without talking to your doctor or pharmacist. Both drugs are effective, and the combination is often better than either drug alone for blood pressure control.
• Verify that your doctor knows you are on both. Ask to see the medications listed in your medical record. If one was prescribed by a different specialist, there is a small chance your primary care doctor is not aware.
• Ensure you have had recent lab work: Your doctor should have checked your potassium, sodium, creatinine, and kidney function (GFR) within the last 3–6 months if you are stable, or within 1–2 weeks if you just started the combination.
• Ask your pharmacist to review your full medication list for other drugs that interact with losartan or hydrochlorothiazide. NSAIDs, other blood pressure drugs, ACE inhibitors, potassium supplements, and even some antibiotics can compound the risks.
• Maintain consistent hydration and avoid excessive sodium restriction (which can paradoxically worsen kidney function with these drugs).
• Do not use potassium salt substitutes unless specifically told to by your doctor.
• Monitor your blood pressure at home if possible. Systolic readings consistently below 120 mmHg or symptoms of dizziness may indicate the need for dose adjustment.

If you are being prescribed this combination for the first time:

• Ask your doctor why both drugs are needed instead of a higher dose of one. The answer usually is that the combination is more effective and sometimes better tolerated, but it is worth understanding the rationale.
• Confirm the specific doses. Starting with lower doses (e.g., losartan 50 mg plus hydrochlorothiazide 12.5 mg) is safer than jumping to higher doses.
• Schedule follow-up lab work for 1–2 weeks after starting. This should include potassium, sodium, creatinine, and kidney function.
• Report symptoms immediately: If you feel dizzy, weak, unusually tired, or develop palpitations (irregular heartbeats) in the first few weeks, contact your doctor the same day.

When to Call Your Doctor or Pharmacist

Contact your healthcare provider immediately if you experience any of the following:

• Severe dizziness or fainting, especially when standing up
• Chest pain, shortness of breath, or severe headache
• Palpitations or irregular heartbeat (suggests potassium imbalance)
• Confusion, extreme fatigue, or muscle weakness (signs of electrolyte imbalance)
• Nausea, vomiting, or severe abdominal pain
• Reduced urine output despite normal fluid intake
• Swelling in the legs, ankles, or feet that was not present before
• Persistent dry cough (rare but can occur with ARBs)

Call during regular business hours if you notice:

• Mild dizziness that does not go away after a few weeks
• Persistent headache or jaw pain
• Questions about your lab results, especially potassium or kidney function values
• New medications prescribed by another doctor that might interact

Key Takeaways

• Losartan and hydrochlorothiazide are safe to take together when appropriately dosed and monitored. The FDA has approved combination products containing both drugs for exactly this purpose.
• The main risks are electrolyte imbalances (high or low potassium and sodium), excessive blood pressure drops, and kidney function decline. These risks are highest in older adults, patients with kidney disease, and those on other medications that affect potassium.
• You must have baseline and periodic lab work showing your potassium, sodium, creatinine, and kidney function (GFR). If you don't have recent labs, ask your doctor to order them.
• Report any new symptoms—dizziness, irregular heartbeats, unusual fatigue, or confusion—to your doctor promptly. These can be signs of a drug reaction or electrolyte imbalance that needs adjustment.
• Work with your pharmacist to ensure no other medications you take compound the risks of this combination. NSAIDs, ACE inhibitors, potassium supplements, and certain antibiotics are common culprits.

Sources

• FDA Drug Labeling via OpenFDA: https://open.fda.gov — Search for "losartan" and "hydrochlorothiazide" for FDA-approved labeling.
• National Institutes of Health, MedlinePlus: Losartan (https://medlineplus.gov/druginfo/meds/a699009.html) and Hydrochlorothiazide (https://medlineplus.gov/druginfo/meds/a682282.html)
• NIH National Library of Medicine, PubMed: Search "losartan hydrochlorothiazide combination therapy" or "ARB thiazide diuretic interaction" for peer-reviewed evidence on safety and efficacy.
• American Heart Association Guidelines on Hypertension Management: Reviewed recommendations for combination antihypertensive therapy.
• Kidney Disease: Improving Global Outcomes (KDIGO): Guidelines on use of angiotensin receptor blockers in chronic kidney disease.

Your medications are powerful tools for managing your health, and when used correctly, losartan and hydrochlorothiazide together can effectively control blood pressure and reduce your risk of heart attack and stroke. The key is informed use and close partnership with your doctor and pharmacist. If you have not had recent lab work or are uncertain about any aspect of your medication regimen, do not wait—contact your healthcare provider or pharmacist today. For a comprehensive review of all your medications and potential interactions, visit checkdruginteractions.com and enter your complete medication list. Our evidence-based checker will flag any concerns and help you have a more informed conversation with your pharmacist or doctor.